GWSG
MREO

GPS Wealth Strategies Group’s Mereo BioPharma MREO Stock Holding History

GPS Wealth Strategies Group’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,500
Closed -$3.09K – 1194
2025
Q3 		$3.09K Hold
1,500
– – ﹤0.01% 1360
2025
Q2 		$4.07K Hold
1,500
– – ﹤0.01% 1250
2025
Q1 		$3.38K Hold
1,500
– – ﹤0.01% 1233
2024
Q4 		$5.25K Hold
1,500
– – ﹤0.01% 1083
2024
Q3 		$6.17K Buy
+1,500
New +$6.21K ﹤0.01% 1046

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

GPS Wealth Strategies Group's MREO Position: Q4 2025 in Review

GPS Wealth Strategies Group sold out of Mereo BioPharma (MREO) in Q4 2025, closing a stake of 1,500 shares — an estimated $3.09K sold.

GPS Wealth Strategies Group first reported a position in MREO in Q3 2024 and held it in 5 quarters. The position peaked at $6.17K in Q3 2024. 70 funds tracked by Wall St. Rank hold MREO as of Q4 2025.

  • GPS Wealth Strategies Group reported no remaining Mereo BioPharma position as of Q4 2025 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 1,500 Mereo BioPharma shares in Q4 2025, an estimated $3.09K.
  • GPS Wealth Strategies Group first reported a position in Mereo BioPharma in Q3 2024 and held it in 5 quarters.
  • GPS Wealth Strategies Group's Mereo BioPharma position peaked at $6.17K in Q3 2024.
  • 70 funds tracked by Wall St. Rank held Mereo BioPharma as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.